Delivery Order SPE2DB20D2104-SPE2DB26FMBEP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Viberzi 100 mg tablets (60-count) with a ceiling value of $1,911.21. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation, and performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Viberzi 75 mg tablets (60 count) valued at $2,354.21. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency awarded a delivery order valued at $1,777.86 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 75 mg on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price contract is non-competitive and was awarded without a set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,960.49 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) on July 15, 2025, with completion scheduled for July 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Viberzi 100 mg tablets (60-count), a pharmaceutical product with a contract ceiling value of $1,761.21. This non-set-aside, competitively awarded delivery order represents a firm fixed price transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg with a ceiling value of $2,122.94 under a firm fixed price contract. This award, issued on September 22, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded, with performance to be fulfilled from the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viberzi 100 mg tablets (60-count) with a ceiling value of $1,718.59. This is a firm fixed-price delivery order issued under a competitively awarded, non-set-aside procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued as a child contract under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of Viberzi 100mg tablets (60-count package) with a ceiling value of $3,415.20. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Viberzi 75 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,707.63. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.60 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) with a firm fixed price and an ultimate completion date of October 20, 2025. This non-set-aside competitive award was issued on October 17, 2025, with performance to be fulfilled at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMBEPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Viberzi 75 mg tablets (60-count) with a ceiling value of $2,106.67. This firm fixed-price delivery order, which is expected to be completed by October 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made without set-aside designation through competitive procurement, reflecting AmerisourceBergen's established capability as a major pharmaceutical distributor to the federal government. The product will be performed and delivered from the contractor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain, supplying pharmaceutical products and medical supplies to support military healthcare programs globally. The company's extensive federal contract portfolio with DLA demonstrates its role as a primary pharmaceutical provider to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Viberzi, a prescription medication, aligns with AmerisourceBergen's documented experience fulfilling federal medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/28/25 |